These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4627581)

  • 41. EVIDENCE FOR AN INITIAL ACCEPTOR OF UDP-NAC-MURAMYL-PENTAPEPTIDE IN THE SYNTHESIS OF BACTERIAL MUCOPEPTIDE.
    STRUVE WG; NEUHAUS FC
    Biochem Biophys Res Commun; 1965 Jan; 18():6-12. PubMed ID: 14265759
    [No Abstract]   [Full Text] [Related]  

  • 42. A COMMON ANTIGEN IN THE CELL WALLS OF THREE LYSOZYME-SENSITIVE BACTERIA.
    WISEMAN D
    J Pharm Pharmacol; 1963 Dec; 15():SUPPL 182-4. PubMed ID: 14101607
    [No Abstract]   [Full Text] [Related]  

  • 43. Utilization of a depsipeptide substrate for trapping acyl-enzyme intermediates of penicillin-sensitive D-alanine carboxypeptidases.
    Rasmussen JR; Strominger JL
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):84-8. PubMed ID: 415311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The antibacterial action of vancomycin.
    Watanakunakorn C
    Rev Infect Dis; 1981; 3 suppl():S210-5. PubMed ID: 6805065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of teichomycin against isolates of gram-positive bacteria.
    Fietta A; Bersani C; Mangiarotti P; Gialdroni Grassi G
    Chemotherapy; 1983; 29(4):275-82. PubMed ID: 6223793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis.
    Singh M; Chang J; Coffman L; Kim SJ
    J Phys Chem B; 2017 Apr; 121(16):3925-3932. PubMed ID: 28368603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mucopeptide turnover in the cell walls of growing cultures of Bacillus megaterium KM.
    CHALOUPKA J; KRECKOVA P; RIHOVA L
    Experientia; 1962 Aug; 18():362-3. PubMed ID: 13877944
    [No Abstract]   [Full Text] [Related]  

  • 48. Inhibition of bacterial growth by beta-chloro-D-alanine.
    Manning JM; Merrifield NE; Jones WM; Gotschlich EC
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):417-21. PubMed ID: 4150023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Structure of the walls of Bacillus megaterium KM. II. Study of the mucopeptide and phosphomucopolysaccharide complexes].
    GHUYSEN JM; LEYH-BOUILLE M; DIERICKX L
    Biochim Biophys Acta; 1962 Sep; 63():297-307. PubMed ID: 13947560
    [No Abstract]   [Full Text] [Related]  

  • 50. The participation of novobiocin and vancomycin in combined antibiotic action against staphylococci.
    BERTIE W; JAWETZ E; SONNE M
    Antibiotic Med Clin Ther (New York); 1957 Jan; 4(1):40-4. PubMed ID: 13382115
    [No Abstract]   [Full Text] [Related]  

  • 51. Getting closer to the real bacterial cell wall target: biomolecular interactions of water-soluble lipid II with glycopeptide antibiotics.
    Vollmerhaus PJ; Breukink E; Heck AJ
    Chemistry; 2003 Apr; 9(7):1556-65. PubMed ID: 12658654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insensitivity of bacteria to proposed antimetabolites of D-alanyl-D-alanine.
    Gale GR; Smith AB
    J Bacteriol; 1973 Apr; 114(1):460-1. PubMed ID: 4698215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. VanX, a bacterial D-alanyl-D-alanine dipeptidase: resistance, immunity, or survival function?
    Lessard IA; Walsh CT
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11028-32. PubMed ID: 10500118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of mucopeptide by L-form membranes.
    Chatterjee AN; Ward JB; Perkins HR
    Nature; 1967 Jun; 214(5095):1311-4. PubMed ID: 6056843
    [No Abstract]   [Full Text] [Related]  

  • 55. The absorption of iodovancomycin by micrococcus lysodeikticus cells.
    Oo KC
    Aust J Exp Biol Med Sci; 1970 Aug; 48(4):397-405. PubMed ID: 5471267
    [No Abstract]   [Full Text] [Related]  

  • 56. Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine.
    Sheldrick GM; Jones PG; Kennard O; Williams DH; Smith GA
    Nature; 1978 Jan; 271(5642):223-5. PubMed ID: 622161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of halothane on bacterial growth rate.
    Wardley-Smith B; Nunn JF
    Br J Anaesth; 1971 Oct; 43(10):919-25. PubMed ID: 4940053
    [No Abstract]   [Full Text] [Related]  

  • 58. Bacterial Lipid II Analogs: Novel In Vitro Substrates for Mammalian Oligosaccharyl Diphosphodolichol Diphosphatase (DLODP) Activities.
    Massarweh A; Bosco M; Chantret I; Léger T; Jamal L; Roper DI; Dowson CG; Busca P; Bouhss A; Gravier-Pelletier C; Moore SEH
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31174247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus.
    Higgins DL; Chang R; Debabov DV; Leung J; Wu T; Krause KM; Sandvik E; Hubbard JM; Kaniga K; Schmidt DE; Gao Q; Cass RT; Karr DE; Benton BM; Humphrey PP
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1127-34. PubMed ID: 15728913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues.
    Allen NE; LeTourneau DL; Hobbs JN
    Antimicrob Agents Chemother; 1997 Jan; 41(1):66-71. PubMed ID: 8980756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.